One study suggested CD26 status may be altered and thus display diverse effects on the growth and metastatic potential in various tumors, explaining the discrepancy in the observation that the absence of CD26 is associated with the development of some cancers, whereas the presence of CD26 is related to a more aggressive phenotype in other tumors [38]. This evidence concerns the gene DPP4 and cancer.